Advancements in cellular therapy for Autoimmune Diseases and Chronic Haematological Malignancies

Join us in Rome from 18–20 September 2025 for an enriching event that will bring together experts, clinicians, and researchers in the fields of haematology, autoimmune diseases, and SCT.
Organised by the Chronic Malignancies Working Party (CMWP) and the Autoimmune Diseases Working Party (ADWP), this event promises the latest updates and evidence-based insights crucial for advancing patient care and research.

Event Highlights Include:
▪ In-depth sessions on cutting-edge topics, such as EBMT disease-specific recommendations for HCT in MDS, autoimmune disorders (AID) and CAR-T in AID, MDS diagnostics and prognostication, sequencing of therapies in myeloma, and novel cellular therapies.
▪ Key presentations by renowned experts on complex subjects, including the application of artificial intelligence in haematologic disorders and novel plasma cell-targeted treatments across both myeloma and rheumatological indications.
▪ Interactive case studies where participants can explore the practical applications of new treatments and horizon scanning for state-of-the-art therapies in AIDs.
▪ Joint physician-nurse sessions emphasising collaborative care approaches in HCT for autoimmune and haematologic diseases.
▪ Networking opportunities to foster connections with global leaders in haematology and immunology.

This event offers a unique opportunity to learn from thought leaders, gain insights into future treatments, and engage in knowledge exchange with colleagues from around the world.

Save the date and get ready to be inspired — we look forward to welcoming you in Rome!

Tobias Alexander - ADWP Chair
Donal McLornan - CMWP Chair
Elisa Roldan-Galvan - ADWP Secretary
Joanna Drozd-Sokolowska - CMWP Co-Secretary
Kavita Raj - Co-Secretary
Carmelo Gurnari - Local organiser
Raffaella Greco - Local organiser

Programme

To access the most recent version of the programme, kindly click on the “Preliminary Programme” document provided above. 

EBMT is thrilled to announce the expansion of the EBMT Travel Grant programme, designed to enhance participation, foster inclusivity, and advance education within our Educational Meetings. These grants intend to alleviate the financial burden of in-person attendance to meetings, covering registration fees, and providing coverage for travel and accommodation expenses. 

Please use the “Case & Grant Submission” button above to start the process. Beware that this submission does not imply the registration to the meeting, so please, do not forget to register by using the “Register” button.

Registration

The registration will close on 14 September 2025, or when is sold out. 

EBMT members can use their CIC code to enjoy the early bird fee until the registration closes or it is sold out. If you are not part of EBMT yet, please consider becoming a member. For more information visit this page.
*Nurses, PhD Students, Physicians in training and Data Managers will need to provide accreditation (ID card or letter from your institution) during the registration process.

Fee includes entry to all sessions, coffee breaks and lunches during the course.

To register, please click on the “Register” button above. You can pay by credit card or wire transfer. Should you need a VISA letter, you’ll be able to download it after the registration process.
If you have any questions, please contact: education.events@ebmt.org and include "CMWP-ADWP 2025 Educational Course" in the subject line.

Registration Cancellation Policy

All cancellations must be electronically mailed or postmarked by using the option "Modify registration".

Refund of registration fees will be as follows:

• In case of cancellation, up until one month prior to the beginning of the meeting, your registration fee will be reimbursed in full (less bank charges).
• If the cancellation is notified between 15 and 30 days prior to the beginning of the meeting, 50% of the registration fee will be reimbursed (less bank charges).
• Cancellations notified between 1 and 15 days registration fee will not be refunded.

Certificate of Attendance

After the event, you will receive an email with a short survey to evaluate the course. Once you have completed it, you will be able to download the certificate of attendance.

Venue

Venue details will be published soon. 

EBAH-CME Accreditation

We are pleased to announce that this educational course will be accredited by the EBAH-CME credits system.

In order to collect your EBAH-CME credits, we recommend that you create an EBAH-CME account by clicking here. By registering on the EBAH-CME website, you will have access to the record of all other events you have already been accredited for. After the meeting, an updated attendance list will be uploaded to the EBAH-CME website.

If you already have an account, you will receive an email to evaluate the course and claim your points. If after 15 days you have not received an email regarding your credits, please contact the EBMT Educational Events Unit at education.events@ebmt.org.

Sponsorship

There are various opportunities to support this meeting. For more information, please email fundraising@ebmt.org to indicate your interest.

ITALIAN REGULATIONS FOR PHARMACEUTICAL COMPANIES PARTICIPATING TO INTERNATIONAL CONGRESSES

The Italian law states that any pharmaceutical company producing, selling, distributing and promoting medicine that wishes to join an international scientific congress or meeting as a sponsor/exhibitor or supporting with sponsored registrations, must submit a request of authorisation  at the Italian Ministry of Health Agency (AIFA) not later than 61 days before the beginning of the event.

For this Ministerial mandatory rule participants drug companies to the Advancements in cellular therapy for Autoimmune Diseases and Chronic Haematological Malignancies Meeting must complete this request of authorisation and we suggest  to do that by the end of June 2025. The process will take place with the support of a local agency acting as provider and point of coordination for every pharmaceutical company taking part to the meeting.

In order to apply, any pharma company needs a SIS code (an informatic token) to communicate informatically with AIFA and forward it’s respective request for the authorization after to initial coordination started by the local agent.

Applicants who do not yet have their SIS CODE, will need to require it and this additional process to obtain this tool is taking no less than an additional 30  days. Therefore, if it is your first time in AIFA procedures, please keep in mind this extra time needed. For the SIS CODE, it is recommended to begin no later than May 20, 2025, considering holiday periods.

We also inform you that pharma companies producing, selling, promoting medical devices are not requested to present any application to AIFA.

PLEASE NOTE: EBMT (organiser of this meeting) is not involved in this procedure, it is the pharmaceutical companies' sole responsibility to adhere to the above regulations directly via the nominated local agent.

For any additional detail on AIFA
(Agenzia Italiana del Farmaco) Remove phone as line service  is suspended
Web: https://www.aifa.gov.it/en/acc

Agent for the coordination:
TWT srl
Email: g.frontani@twt-team.it / alupidi@twt-team.it
Tel: +39 06 44249321
Via Arrigo Davila 130
00179 ROME – Italy